On this matter, long-term treatment with MCC950, a highly selective inhibitor of NLRP3, was shown to be beneficial in the treatment of mood disorders [75], neurodevelopmental diseases [76], and neurodegenerative diseases such as Alzheimer’s and Huntington’s disease [77]. Here, NLRP3 is linked to juvenile Huntington disease.